THEME: "Exploring the Challenges in Pre & Post Formulations and Drug Delivery Systems"
King Abdulaziz University, Saudi Arabia
Title: The promising use of nano-molecular imprinted templates for improved SARS-CoV-2 detection, drug delivery and research
Alaa F. Nahhas’s degrees are in biochemistry from the King Abdulaziz University (B.S., 2006) and in biomedical engineering and biotechnology from University of Massachusetts (Ph.D., 2017). She currently serves as an Assistant Professor of Biochemistry at King Abdulaziz University.
Molecular
imprinting (MI) is a technique that creates a template of a molecule for
improving complementary binding sites in terms of size and shape to a peptide,
protein, bacteria, mammalian cell, or virus on soft materials (such as
polymers, hydrogels, or self-assembled materials). MI has been widely
investigated for over 90 years in various industries but is now focused on
improved tissue engineering, regenerative medicine, drug delivery, sensors,
diagnostics, therapeutics and other medical applications. Molecular targets
that have been studied so far in MI include those for the major antigenic
determinants of microorganisms (like bacteria or viruses) leading to
innovations in disease diagnosis via solid-phase extraction separation and
biomimetic sensors. As such, although not widely investigated yet, MI
demonstrates much promise for improving the detection of and treatment for the
current Coronavirus Disease of 2019 (COVID-2019) pandemic as well as future pandemics. In this
manner, this review will introduce the numerous applications of MI polymers,
particularly using proteins and peptides, and how these MI polymers can be used
as improved diagnostic and therapeutic tools for COVID-19